Medtronic is making customers aware of a potential cybersecurity risk. Security researchers have identified potential cybersecurity vulnerabilities related to the listed insulin pumps. An unauthorized person with special technical skills and equipment could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery. This could lead to hypoglycemia (if additional insulin is delivered) or hyperglycemia and diabetic ketoacidosis (if not enough insulin is delivered). At this time, Medtronic has received no confirmed reports of unauthorized persons changing settings or controlling insulin delivery.